Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5million.

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Mobile health IT: The effect of user interface and form factor on doctor–patient communication Ole Andreas Alsos, Anita Das, Dag Svanæs International Journal.

Fellows' perspectives on training in adult congenital heart disease: Results of a survey from the International Society for Adult Congenital Heart Disease.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/AHA 2011 Expert Consensus Document on Hypertension.

Hazard ratio (& 95% CI) for 20 mmHg lower usual systolic BP

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network.

Community-Based Mind–Body Meditative Tai Chi Program and Its Effects on Improvement of Blood Pressure, Weight, Renal Function, Serum Lipoprotein, and.

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Teaching Tool: Blood Pressure Classification

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study Ido Weinberg, Philimon Gona, Christopher.

Volume 375, Issue 9709, Pages (January 2010)

Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Lymph Node Dissection in Clinical Stage I Lung Cancer: A Meta-Analysis and System Review Wenxiong.

Body-mass index and all-cause mortality – Authors' reply

Seizure - European Journal of Epilepsy

Erik O. Udo, Norbert M. van Hemel, Nicolaas P. A

A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both Nadia Aissaoui, Edith Martins,

Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort Dexter Canoy, Benjamin J. Cairns, Angela.

Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations Judith A. Finegold,

Alan Gradman Journal of Indian College of Cardiology

Volume 63, Issue 3, Pages (March 2013)

Prospective Studies Collaboration Lancet 2009; 373:

CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies

PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials Xiao-Dong Zhuang, Ming Long, Fei Li, Xun.

What does STOP-2 tell us about management of hypertension?

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta- analysis of individual participant data from randomised trials

Age-specific relevance of usual blood pressure to vascular mortality

Qing Ye, Wen-xia Shao, Shi-qiang Shang, Ming-ming Zhou

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study C.A. Rushton, U.T. Kadam International.

Adriana K. Burlá, Núbia S. Lobato, Zuleica B

Body-mass index and all-cause mortality – Authors' reply

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Prospective Studies Collaboration The.

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

Volume 352, Pages S15-S18 (October 1998)

Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation C. Mary.

Volume 379, Issue 9822, Pages (March 2012)

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Salvatore Patanè,

Kamran Manzoor, Waqas Aftab, Sonia Choksi, Ijaz A. Khan

Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China Iona Y Millwood, DPhil,

A new automated system to identify a consistent sampling position to make tissue Doppler and transmitral Doppler measurements of E, E′ and E/E′ Niti.

MRC/BHF Heart Protection Study

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

Exercise training for pulmonary hypertension: A systematic review and meta-analysis Ping Yuan, Xun-Tao Yuan, Xiu-Ying Sun, Bigyan Pudasaini, Jin-Ming.

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Body-mass index, blood pressure, and cause-specific mortality in India: a prospective cohort study of 500 810 adults Vendhan Gajalakshmi, PhD, Ben Lacey,

Experiences of air travel in patients with chronic heart failure

Yingnan Bian, Suhua Zhang, Zheng Wang, Ruxin Zhu, Qi Zhao, Chengtao Li

Cardiovascular health, risks and diseases in contemporary China

Volume 379, Issue 9822, Pages (March 2012)

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

David Montero, Agnès Vinet, Christian K. Roberts

Volume 381, Issue 9871, Pages (March 2013)

Erratum to “Tako-tsubo cardiomyopathy may be associated with cardiac geometric features as observed in hypertensive heart disease” [Int. J. Cardiol. 135.

Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into.

Three-dimensional echocardiographic diagnosis of a giant congenital diverticulum of the left ventricular outflow tract Jiani Liu, Xiaoling Zhang, Xi.

Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in Western China Xinping Zhang, Minmin Zhu, Hassan H. Dib, Jian.

Right bundle branch block with revelation of changing axis deviation at the end of atrial fibrillation Salvatore Patanè, Filippo Marte, Mauro Sturiale

Vaikom S. Mahadevan, Petra Jenkins, Akbar Vohra, Ragheb Hasan, J

International Journal of Cardiology

Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension Johannes M. Douwes, Marcus T.R. Roofthooft,

Cardiac ion channel mutations in the sudden infant death syndrome

Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis

Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms Robert M. Kwee, MD Journal of Vascular.

Presentation transcript:

Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5million people Yiping Chen, Liming Li, Qiuli Zhang, Robert Clarke, Junshi Chen, Yu Guo, Zheng Bian, Xianhai Pan, Richard Peto, Ran Tao, Kunxiang Shi, Rory Collins, Liangcai Ma, Huarong Sun, Zhengming Chen International Journal of Cardiology Volume 172, Issue 1, Pages 88-95 (March 2014) DOI: 10.1016/j.ijcard.2013.12.065 Copyright © 2013 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Percentage use of six proven CVD medication categories by level of education in participants with a history of IHD (left) or stroke (right). Vertical lines indicate 95% CIs. International Journal of Cardiology 2014 172, 88-95DOI: (10.1016/j.ijcard.2013.12.065) Copyright © 2013 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Odds ratio of use of six proven CVD medication categories by levels of systolic blood pressure in participants with a history of cardiovascular disease. Numbers of people with prior CVD are also given for each group. Odds ratios are plotted on a floating absolute scale. Each closed square has an area inversely proportional to the effective variance of the log of the odds ratio. Vertical lines indicate 95% CIs. International Journal of Cardiology 2014 172, 88-95DOI: (10.1016/j.ijcard.2013.12.065) Copyright © 2013 Elsevier Ireland Ltd Terms and Conditions

Fig. 3 Percentage use of six proven CVD medication categories in participants with and without doctor-diagnosed hypertension among those with IHD (left) and stroke (right). Vertical lines indicate 95% CIs. International Journal of Cardiology 2014 172, 88-95DOI: (10.1016/j.ijcard.2013.12.065) Copyright © 2013 Elsevier Ireland Ltd Terms and Conditions